|Articles|April 1, 2011

Optical Biometry

Dr Paul-Rolf Preussner discusses how additional optical measurements are required to improve the accuracy limits in IOL calculation

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Subscribe

Related Content

Visual training may ease neuroadaptation to presbyopia-correcting IOLs

ByDavid P. Piñero, PhD

September 5th 2026

Single-use instruments in cataract surgery: Beyond the backup role

ByBen LaHood, PhD, PGDipOphth, MBChB, FRANZCO

August 7th 2026

Synthetic corneal implant shows promise in eyes with chronic corneal oedema

ByOphthalmology Times Europe Staff

July 4th 2026

Mikhail Boukhny and Andy Chang | Ophthalmology Times Europe

Hands-on training, real surgeon input: inside BVI's new Experience Hub

ByMikhail Boukhny,Andy Chang,Lucia Gambuzza

July 3rd 2026

How the ocular microbiome may shape outcomes in keratoplasty

ByOphthalmology Times Europe Staff

July 2nd 2026

Latest CME

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Optical Biometry

Related Content

Visual training may ease neuroadaptation to presbyopia-correcting IOLs

Single-use instruments in cataract surgery: Beyond the backup role

Synthetic corneal implant shows promise in eyes with chronic corneal oedema

Hands-on training, real surgeon input: inside BVI's new Experience Hub

How the ocular microbiome may shape outcomes in keratoplasty

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery